Pages that link to "Q47825002"

The following pages link to A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia. (Q47825002):

Displaying 37 items.

• Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaedit (Q21032449) (← links)
• Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria (Q24201077) (← links)
• Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria (Q24202910) (← links)
• Artemisinin-based combination therapy for treating uncomplicatedPlasmodium vivaxmalaria (Q24235351) (← links)
• Artemisinin-based combination therapy for treating uncomplicated malaria (Q24241785) (← links)
• The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data (Q26822489) (← links)
• Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties (Q26866187) (← links)
• A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru (Q28469333) (← links)
• Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial (Q28541521) (← links)
• Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia (Q30240158) (← links)
• Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières (Q33358271) (← links)
• Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis (Q33489551) (← links)
• The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread (Q33655603) (← links)
• Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool (Q33875677) (← links)
• The story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study (Q34329292) (← links)
• A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos (Q34341784) (← links)
• Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa (Q35189138) (← links)
• Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment (Q35859839) (← links)
• Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study (Q36309099) (← links)
• Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model (Q36422706) (← links)
• Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. (Q36558557) (← links)
• Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study (Q36689509) (← links)
• Cost of increasing access to artemisinin combination therapy: the Cambodian experience (Q36700468) (← links)
• In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes (Q36757694) (← links)
• Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro (Q37144854) (← links)
• Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers (Q37263344) (← links)
• Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda (Q37263818) (← links)
• Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand (Q37358872) (← links)
• Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia (Q37366389) (← links)
• Existing antimalarial agents and malaria-treatment strategies (Q37492591) (← links)
• Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study (Q37562847) (← links)
• Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies (Q38065917) (← links)
• Efficacy and safety of artesunate-mefloquine therapy for treating uncomplicated Plasmodium falciparum malaria: systematic review and meta-analysis (Q39063353) (← links)
• Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study (Q39483732) (← links)
• Artemisinin resistance on the Thai-Cambodian border. (Q45884419) (← links)
• Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam (Q46075114) (← links)
• High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia (Q91804619) (← links)